ALCESTER-based Quanta Dialysis Technologies Ltd has raised $245million in the largest private funding round for a dialysis device company in history.
Quanta, which also has a base in Beverley, Massachusetts in the United States, is a medical technology leader with a vision of more flexible and accessible dialysis care for people with kidney failure.
The funding round was oversubscribed too pointing to a strong interest in what the firm has to offer.
“We are delighted to attract such a strong syndicate of investors, which represents a clear vote of confidence in our innovative approach to dialysis treatment,” said chief executive John E Milad.
“Everybody knows that dialysis care must improve.
“For this to happen, providers and physicians need products that allow greater flexibility to bring dialysis directly to the patient, while simplifying complexity and reducing the overall cost of care.
“Our small, simple-to-use, and powerful dialysis system SC+ is positioned to help transform kidney care.
The funding we are announcing will allow us to accelerate our emergence as a significant force in this market.”
Quanta’s award-winning portable hemodialysis system SC+ is the only next-generation system that delivers the performance and dose equivalence of larger, traditional dialysis systems while also offering the portability, digital connectivity and ease-of-use of a dialysis device.
Additionally, Quanta’s companion water purification module works with SC+ as an all-in-one mobile stack allowing dialysis treatments to
be delivered in settings with just a standard water supply.
Chronic kidney disease patients currently have to spend many hours on multiple days each week in a dialysis clinic.
Quanta are based on Tything Road in Alcester.
